FFA
FLNA

Farther Finance Advisors’s Filana Therapeutics FLNA Stock Holding History

Farther Finance Advisors’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19 Hold
16
– – ﹤0.01% 5903
2026
Q1 		$28 Sell
16
-78
-83% -$161 ﹤0.01% 5620
2025
Q4 		$186 Sell
94
-1
-1% -$3 ﹤0.01% 5215
2025
Q3 		$276 Sell
95
-334
-78% -$768 ﹤0.01% 4656
2025
Q2 		$776 Buy
429
+314
+273% +$559 ﹤0.01% 3955
2025
Q1 		$159 Buy
+115
New +$290 ﹤0.01% 3993
2024
Q3 		– Sell
-5
Closed -$61 – 4107
2024
Q2 		$61 Buy
+5
New +$105 ﹤0.01% 3669
2024
Q1 		– Sell
-1
Closed -$23 – 3719
2023
Q4 		$23 Buy
+1
New +$21 ﹤0.01% 3449

Other funds holding FLNA

AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
JIC
Johnson Investment Counsel Cincinnati, Ohio $13.7B AUM 21.52% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
SIC
Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return
SWA
SOA Wealth Advisors New York $595M AUM 25.98% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
GSWM
Golden State Wealth Management Santa Ana, California $1.1B AUM 27.49% 1-Year Est. Return

Farther Finance Advisors's FLNA Position: Q2 2026 in Review

Farther Finance Advisors held its Filana Therapeutics (FLNA) position steady in Q2 2026 at 16 shares worth $19. The position accounts for ﹤0.01% of the portfolio, ranked #5903.

Farther Finance Advisors first reported a position in FLNA in Q4 2023 and has held it in 8 quarters since. The position peaked at $776 in Q2 2025. 14 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.

  • Farther Finance Advisors held 16 shares of Filana Therapeutics worth $19 as of Q2 2026.
  • Farther Finance Advisors left its Filana Therapeutics share count unchanged in Q2 2026.
  • Filana Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5903 holding.
  • Farther Finance Advisors first reported a position in Filana Therapeutics in Q4 2023 and has held it in 8 quarters since.
  • Farther Finance Advisors's Filana Therapeutics position peaked at $776 in Q2 2025.
  • 14 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.